risedronic acid has been researched along with Cushing Syndrome in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gencer-Atalay, K | 1 |
| Ozturk, EC | 1 |
| Yagci, I | 1 |
| Ata, P | 1 |
| Delil, K | 1 |
| Ozgen, Z | 1 |
| Akyuz, G | 1 |
1 review available for risedronic acid and Cushing Syndrome
| Article | Year |
|---|---|
Challenges in the treatment of fibrodysplasia ossificans progressiva.
Topics: Adolescent; Anti-Inflammatory Agents; Bone Density Conservation Agents; Breathing Exercises; Cushing | 2019 |